1356009-48-7

Upstream product

• 1356009-59-0 tert-butyl (5-(2-(3-methyl-1H-1,2,4-triazol-1-yl)-5-nitrophenoxy)pentan-2-yl)carbamate 
• 1356009-55-6 tert-butyl 5-bromopentan-2-ylcarbamate 
• 1356009-25-0 2-(3-methyl-1H-1,2,4-triazol-1-yl)-5-nitrophenol 
• 1356009-23-8 1-(2-(4-methoxybenzyloxy)-4-nitrophenyl)-3-methyl-1H-1,2,4-triazole 
• 1351353-49-5 1-chloro-2-((4-methoxybenzyl)oxy)-4-nitrobenzene 
• 619-10-3 5-nitro-2-chlorophenol 
• 927-55-9 (±)-4-amino-1-pentanol 
• 1009-36-5 2-chloro-5-nitroanisole 
• 179412-96-5 tert-butyl (4-hydroxy-1-methylbutyl)carbamate 

Downstream Products

• 1356009-99-8 2-chloro-7-(2,4-difluorophenyl)-N-(5-(2-(3-methyl-1H-1,2,4-triazol-1-yl)-5-nitrophenoxy)pentan-2-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine 
• 1356010-60-0 N-(5-(5-amino-2-(3-methyl-1H-1,2,4-triazol-1-yl)phenoxy)pentan-2-yl)-2-chloro-7-(2,4-difluorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine 
• 1356008-77-9 18-(2,4-difluorophenyl)-13-methyl-7-(3-methyl-1H-1,2,4-triazol-1-yl)-10,11,12,13,14,16,17,18-octahydro-3H-15,2-(azeno)-4,8-(metheno)cyciopenta[h][1,6,10,12]oxatriazacycloheptadecine 

Relevant academic research and scientific papers

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof: which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by -amyloid peptide (β-AP) production.